focus -WSS

focus

author：hotspot 2025-09-02 08:15:24 - browse：71268

UnitedHealth Group appears to be offering some providers more substantial loans in the wake of the cyberattack on Change Healthcare, according to three doctors who each saw their advances increase up to seven figures.

The apparent change comes as hospitals, doctors, and lobbying groups have for weeks complained about low offers from the company, in some cases less than 1% of their typical weekly billing. Initially, after a mid-February cyberattack took its system offline, hampering insurers’ ability to receive claims and send payments, UnitedHealth offered loans to bridge the gap while the company worked to fix the outage, but many providers said it didn’t accomplish that.

It’s not clear exactly what prompted the change in these providers’ offers, or how broadly it applies. The new offers came just days after UnitedHealth officials met virtually with Health and Human Services Secretary Xavier Becerra and other White House officials. At that meeting, HHS said it explicitly asked UnitedHealth to send advance payments to providers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

hotspot

WSS

Questions loom on AstraZeneca cancer drug as safety concerns ebb

IVF doctors demand details after CooperSurgical lawsuit

Ozempic has benefits for kidney disease as well as diabetes

Fetal cell organoids grown from amniotic fluid, study finds

Roche drug slashes death risk in early

CZI to create biohub to build anti

focus

focus

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

For AI in health care standards, federal regulators join with industry group

BioMarin wins approval for gene therapy to treat hemophilia A

Why a market frenzy over new weight loss drugs defies logic

Cancer drug shortages should be causing more outrage

Why a market frenzy over new weight loss drugs defies logic

Peter Hotez and the public health issue of online harassment

Streamlined flu vaccines recommended by FDA advisory panel

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT Summit: How researchers deal with rejection

focus

Results on Novartis prostate cancer therapy could expand its use

Readout LOUD podcast: Live from the 2023 STAT Summit

ADCs take center stage as promising cancer treatments

How AI can help patients find reliable information about doctors

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Stem cell biologist probes earliest stages of human development

entertainment

focus

hotspot

focus